Invention Grant
- Patent Title: Use of whey permeate for the treatment of metabolic syndrome
-
Application No.: US13930693Application Date: 2013-06-28
-
Publication No.: US09770468B2Publication Date: 2017-09-26
- Inventor: Jobst Krauskopf , Christian Sowada
- Applicant: “S.U.K.” BETEILIGUNGS GMBH
- Agency: Scully Scott Murphy and Presser
- Priority: DE10331202 20030710
- Main IPC: A61K35/20
- IPC: A61K35/20 ; A61K31/19 ; A61K31/7016 ; A23L33/18 ; A23L33/19
Abstract:
The invention relates to the use of whey permeate, preferably sweet whey permeate and more preferably hydrolysed or partially-hydrolysed sweet whey permeate for the production of a pharmaceutical composition for prophylaxis or treatment of symptoms of metabolic syndrome, type-2 diabetes and secondary diseases, said composition being provided for a mammal.
Public/Granted literature
- US20140017282A1 USE OF WHEY PERMEATE FOR THE TREATMENT OF METABOLIC SYNDROME Public/Granted day:2014-01-16
Information query
